CARDINAL HEALTH INC

Listed Company

CAHCIK 0000721371NYSELarge AcceleratedWholesale-Drugs, Proprietaries & Druggists' SundriesOhioFY ends Jun 30

Period

FY 2025

Revenue

$222.58B

Net Income

$1.56B

Total Assets

$53.12B

Equity

$-2.78B

Shares Out

234.21M

Op. Cash Flow

$2.40B

Business

Cardinal Health, Inc. is a global healthcare services and products company that provides customized solutions to hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician practices, and patients at home. It offers medical products and pharmaceuticals along with distribution, pharmacy management, specialty services, consulting, data analytics, supply chain and logistics solutions, and home medical supply services. Major operating segments include Pharmaceutical and Specialty Solutions, Global Medical Products and Distribution (GMPD), Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics. Its products and services are sold and distributed through direct sales, third-party distributors, group purchasing organizations, managed service organizations, and e-commerce channels across the United States, Canada, Europe, Asia, Latin America, and other international markets.

Summary from filing dated 2025-08-12

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Revenue	222,578	226,827	204,979	181,326	162,467
Cost of products sold	214,410	219,413	198,105	174,842	155,689
Gross margin	8,168	7,414	6,874	6,484	6,778
Distribution, selling, general, and administrative expenses	5,382	5,000	4,800	4,512	4,533
Restructuring and employee severance	88	175	95	101	114
Amortization and other acquisition-related costs	464	284	285	324	451
Acquisition-related cash and share-based compensation costs [Line Items]	126	0	0	—	—
Impairments and (gain)/loss on disposal of assets, net	18	634	1,246	2,060	79
Litigation (recoveries)/charges, net	−185	78	−304	94	1,129
Operating earnings	2,275	1,243	752	−607	472
Other (income)/expense, net	−41	−9	5	22	−47
Interest expense, net	215	51	84	147	180
Earnings before income taxes	2,101	1,201	663	−784	323
Income Tax Expense (Benefit)	532	348	332	153	−289
Net earnings	1,569	853	331	−937	612
Less: Net earnings attributable to noncontrolling interests	−8	−1	−1	−1	−1
Net earnings attributable to Cardinal Health, Inc.	1,561	852	330	−938	611
Basic (in dollars per share)	6.48	3.48	1.27	−3.37	2.09
Diluted (in dollars per share)	6.45	3.45	1.26	−3.37	2.08
Basic (in shares)	241	245	261	279	292
Diluted (in shares)	242	247	262	279	294

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Cash and equivalents	3,874	5,133	4,076	4,717	3,407
Trade receivables, net	13,242	12,084	11,108	10,561	9,103
Inventories, net	16,831	14,957	16,119	15,636	14,594
Prepaid expenses and other	2,414	2,663	2,294	2,021	2,843
Assets held for sale	12	47	140	0	1,101
Total current assets	36,373	34,884	33,737	32,935	31,048
Property and equipment, net	2,858	2,529	2,461	2,361	2,360
Goodwill and other intangibles, net	12,177	6,450	6,085	7,629	10,094
Other assets	1,714	1,258	1,066	953	951
Total assets	53,122	45,121	43,349	43,878	44,453
Accounts payable	34,713	31,759	29,934	27,128	23,700
Current portion of long-term obligations and other short-term borrowings	550	434	792	580	871
Other accrued liabilities	3,634	3,447	2,972	2,842	2,957
Total current liabilities	38,897	35,640	33,740	30,550	27,624
Long-term obligations, less current portion	7,977	4,658	3,909	4,735	5,365
Deferred income taxes and other liabilities	8,882	8,035	8,657	9,299	9,670
Authorized500 thousand shares, Issuednone	0	0	0	0	0
Authorized755 million shares, Issued 271 million shares 327 million shares at June 30, 2025 and 2024, respectively	2,956	2,917	2,746	2,813	2,806
Retained earnings/(accumulated deficit)	783	−286	−642	−280	1,205
Common shares in treasury, at cost: 32 million shares and 83 million shares at June 30, 2025 and 2024, respectively	−6,365	−5,677	−4,911	−3,128	−2,186
Accumulated other comprehensive loss	−155	−167	−151	−114	−34
Total Cardinal Health, Inc. shareholders' deficit	−2,781	−3,213	−2,958	−709	1,791
Noncontrolling interests	147	1	1	3	3
Total shareholders deficit	−2,634	−3,212	−2,957	−882	1,623
Total liabilities and shareholders deficit	53,122	45,121	43,349	43,878	44,453

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30
Depreciation and amortization	790	710	692	692	783
Impairments and loss on sale of other investments	3	2	7	24	0
Share-based compensation	244	121	96	81	89
Provision for/(benefit from) deferred income taxes	243	−104	−40	14	496
Provision for bad debts	53	36	55	23	65
Increase in trade receivables	−833	−996	−950	−1,405	−904
(Increase)/decrease in inventories	−1,816	1,115	−412	−1,204	−1,584
Increase in accounts payable	2,732	1,824	2,816	3,555	2,325
Other accrued liabilities and operating items, net	−606	−433	−997	264	452
Net cash provided by operating activities	2,397	3,762	2,844	3,175	2,429
Additions to property and equipment	−547	−511	−481	−387	−400
Acquisition of subsidiaries, net of cash acquired	−5,250	−1,190	−10	−22	−3
Proceeds from net investment hedge terminations	2	34	29	71	0
Purchase of short-term time deposits	0	−550	0	0	—
Proceeds from short-term investment in time deposit	200	350	0	0	—
Increase (decrease) in other investing items, net	2	18	8	—	—
Net cash used in investing activities	−5,593	−1,849	−454	567	−378
Proceeds from long-term obligations, net of issuance costs	3,669	1,139	0	0	—
Purchase of noncontrolling interests	12	0	3	0	0
Reduction of long-term obligations	−445	−783	−579	−885	−570
Net tax proceeds/(withholding) from share-based compensation	−13	46	56	−19	8
Dividends on common shares	−494	−499	−525	−559	−573
Net cash provided by/(used in) financing activities	1,940	−847	−3,051	−2,463	−1,317
Effect of exchange rates changes on cash and equivalents	−3	−9	−8	−25	11
Net increase/(decrease) in cash and equivalents	−1,259	1,057	−669	1,363	636
Cash payments for interest	315	214	203	153	182
Net cash payments for income taxes	444	191	156	−766	273

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro